Ali S, Dwivedi Y
Mol Neurobiol. 2024; 62(4):5297-5310.
PMID: 39532806
PMC: 11880062.
DOI: 10.1007/s12035-024-04578-7.
Laurencin C, Lancelot S, Merida I, Costes N, Redoute J, Le Bars D
Biomolecules. 2023; 13(5).
PMID: 37238713
PMC: 10216046.
DOI: 10.3390/biom13050843.
Marquez-Franco R, Carrillo-Ruiz J, Velasco A, Velasco F
Front Psychiatry. 2022; 12:764776.
PMID: 35250649
PMC: 8888660.
DOI: 10.3389/fpsyt.2021.764776.
Brocos-Mosquera I, Miranda-Azpiazu P, Muguruza C, Corzo-Monje V, Morentin B, Meana J
Transl Psychiatry. 2021; 11(1):643.
PMID: 34930904
PMC: 8688495.
DOI: 10.1038/s41398-021-01762-4.
Duan K, Fang C, Yang S, Yang S, Xiao J, Chang H
Front Genet. 2021; 12:675386.
PMID: 34306020
PMC: 8294467.
DOI: 10.3389/fgene.2021.675386.
Potential depressive central nervous system effects of brimonidine topical gel.
Foschi C, Damstetter E
JAAD Case Rep. 2020; 6(10):979-980.
PMID: 32995423
PMC: 7508708.
DOI: 10.1016/j.jdcr.2020.07.037.
Monoaminergic System Modulation in Depression and Alzheimer's Disease: A New Standpoint?.
Morgese M, Trabace L
Front Pharmacol. 2019; 10:483.
PMID: 31156428
PMC: 6533589.
DOI: 10.3389/fphar.2019.00483.
Radioligand binding analysis of α adrenoceptors with [C]yohimbine in brain in vivo: Extended Inhibition Plot correction for plasma protein binding.
Phan J, Landau A, Jakobsen S, Wong D, Gjedde A
Sci Rep. 2017; 7(1):15979.
PMID: 29167492
PMC: 5700124.
DOI: 10.1038/s41598-017-16020-1.
The GTPase Rab43 Controls the Anterograde ER-Golgi Trafficking and Sorting of GPCRs.
Li C, Wei Z, Fan Y, Huang W, Su Y, Li H
Cell Rep. 2017; 21(4):1089-1101.
PMID: 29069590
PMC: 6051424.
DOI: 10.1016/j.celrep.2017.10.011.
Therapeutic Potential of Selectively Targeting the α-Adrenoceptor in Cognition, Depression, and Schizophrenia-New Developments and Future Perspective.
Uys M, Shahid M, Harvey B
Front Psychiatry. 2017; 8:144.
PMID: 28855875
PMC: 5558054.
DOI: 10.3389/fpsyt.2017.00144.
Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD/FADD ratio after chronic desipramine and fluoxetine administration.
Garcia-Fuster M, Garcia-Sevilla J
Psychopharmacology (Berl). 2016; 233(15-16):2955-71.
PMID: 27259485
DOI: 10.1007/s00213-016-4342-6.
Genetic variants in combination with early partial improvement as a clinical utility predictor of treatment outcome in major depressive disorder: the result of two pooled RCTs.
Kato M, Serretti A, Nonen S, Takekita Y, Wakeno M, Azuma J
Transl Psychiatry. 2015; 5:e513.
PMID: 25710119
PMC: 4445755.
DOI: 10.1038/tp.2015.6.
The neurobiology of suicide - A Review of post-mortem studies.
Furczyk K, Schutova B, Michel T, Thome J, Buttner A
J Mol Psychiatry. 2014; 1(1):2.
PMID: 25408895
PMC: 4223890.
DOI: 10.1186/2049-9256-1-2.
Cannabinoid modulation of alpha2 adrenergic receptor function in rodent medial prefrontal cortex.
Cathel A, Reyes B, Wang Q, Palma J, Mackie K, Van Bockstaele E
Eur J Neurosci. 2014; 40(8):3202-14.
PMID: 25131562
PMC: 4205194.
DOI: 10.1111/ejn.12690.
α2 adrenergic receptor dysregulation in depressive disorders: implications for the neurobiology of depression and antidepressant therapy.
Cottingham C, Wang Q
Neurosci Biobehav Rev. 2012; 36(10):2214-25.
PMID: 22910678
PMC: 3508310.
DOI: 10.1016/j.neubiorev.2012.07.011.
Cannabinoid modulation of noradrenergic circuits: implications for psychiatric disorders.
Carvalho A, Van Bockstaele E
Prog Neuropsychopharmacol Biol Psychiatry. 2012; 38(1):59-67.
PMID: 22296986
PMC: 3351574.
DOI: 10.1016/j.pnpbp.2012.01.008.
Cellular consequences of stress and depression.
Fuchs E, Flugge G
Dialogues Clin Neurosci. 2011; 6(2):171-83.
PMID: 22033809
PMC: 3181796.
The antidepressant desipramine is an arrestin-biased ligand at the α(2A)-adrenergic receptor driving receptor down-regulation in vitro and in vivo.
Cottingham C, Chen Y, Jiao K, Wang Q
J Biol Chem. 2011; 286(41):36063-36075.
PMID: 21859713
PMC: 3195605.
DOI: 10.1074/jbc.M111.261578.
Chronic desipramine treatment alters tyrosine hydroxylase but not norepinephrine transporter immunoreactivity in norepinephrine axons in the rat prefrontal cortex.
Erickson S, Gandhi A, Asafu-Adjei J, Sampson A, Miner L, Blakely R
Int J Neuropsychopharmacol. 2011; 14(9):1219-32.
PMID: 21208501
PMC: 3117082.
DOI: 10.1017/S1461145710001525.
Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment.
Yanpallewar S, Fernandes K, Marathe S, Vadodaria K, Jhaveri D, Rommelfanger K
J Neurosci. 2010; 30(3):1096-109.
PMID: 20089918
PMC: 2880491.
DOI: 10.1523/JNEUROSCI.2309-09.2010.